CyberKnife robotic radiosurgery system for tumor treatment (Q37004652)

17 August 2017

1 reference

title

CyberKnife robotic radiosurgery system for tumor treatment (English)

1 reference

17 August 2017

Wendy Hara

1

1 reference

PubMed ID

18020920

17 August 2017

Scott G Soltys

series ordinal

2

1 reference

PubMed ID

18020920

17 August 2017

Iris C Gibbs

series ordinal

3

1 reference

17 August 2017

1 November 2007

1 reference

Expert Review of Anticancer Therapy

17 August 2017

1 reference

17 August 2017

7

1 reference

17 August 2017

1507-1515

1 reference

17 August 2017

11

1 reference

Stereotactic radiosurgery of the brain using the first United States 201 cobalt-60 source gamma knife

17 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Staged stereotactic irradiation for acoustic neuroma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

CyberKnife stereotactic radiosurgical treatment of spinal tumors for pain control and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

CyberKnife radiosurgery for spinal neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Cyberknife radiosurgery for metastatic spine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Image-guided robotic radiosurgery for spinal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Phase I clinical evaluation of near-simultaneous computed tomographic image-guided stereotactic body radiotherapy for spinal metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

CyberKnife radiosurgery for benign intradural extramedullary spinal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

CyberKnife frameless single-fraction stereotactic radiosurgery for benign tumors of the spine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Multisession CyberKnife radiosurgery for intramedullary spinal cord arteriovenous malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Stereotactic radiosurgery for patients with cancer of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Image-guided radiosurgery of head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Stereotactic body radiation therapy in multiple organ sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Interim analysis of a prospective phase I/II trial of SBRT for liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Is alpha/beta for prostate tumors really low?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.7.11.1507

10.1586/14737140.7.11.1507

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18020920